PBC News
-
Our Bioscience Economy
InBusiness Greater Phoenix recently looked at the Phoenix bioscience and health care ecosystem, and how the sector is transforming our economy. You can read an excerpt of the piece below. “We […]
-
Phoenix Bioscience Core Newsletter
This is a web version of our weekly Phoenix Bioscience Core Newsletter. Welcome to the Phoenix Bioscience Core’s weekly newsletter, featuring the latest news and announcements from around the PBC, upcoming events, and interesting things happening in the community.
-
Fueling a Bioscience Powerhouse
ASU’s Thrive Magazine features the Phoenix Bioscience Core and its role in driving Phoenix’s life sciences innovation ecosystem.
-
Phoenix expands the bio research campus brand; welcomes the Phoenix Bioscience Core
Recognizing its role at the center of driving translational discovery, Phoenix is rebranding the campus as the Phoenix Bioscience Core. The core partnership involves various major bioscience research organizations, including the Arizona Board of Regents, Arizona State University, Northern Arizona University, University of Arizona, Translational Genomics Research Institute (TGen), Dignity Health and others.
-
University of Arizona College of Medicine – Phoenix 2022 Match Day Recap
-
TGen, HonorHealth and Irish biomedical team initiate promising ‘Nieto’ clinical trial against pancreatic cancer
association with HonorHealth Research and Innovation Institute and Systems Biology Ireland (SBI), have begun a clinical trial, testing the combination of two drugs against advanced pancreatic cancer, one of the most deadly and difficult-to-treat malignancies.
-
Banner, UArizona, SpaceX partner to host pioneering fellowship in aerospace surgery
Banner – University Medical Center Phoenix will host the first-ever Aerospace Surgery Fellowship beginning this July. In partnership with the University of Arizona College of Medicine – Phoenix and SpaceX, this comprehensive formal training in the field of aerospace medicine, with specific emphasis on surgical and procedural expertise, is not currently offered anywhere in the…
-
OncoMyx appoints Robert Williamson Chief Business and Chief Financial Officer
OncoMyx Therapeutics, a privately-held oncolytic virus immunotherapy company, today announced the appointment of Robert Williamson as Chief Business and Chief Financial Officer.
Got any book recommendations?